- Research article
- Open Access
Dysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivation
© Tanaka; licensee BioMed Central Ltd. 2008
- Received: 06 September 2007
- Accepted: 25 April 2008
- Published: 25 April 2008
The GABAergic system in the brain seems to be dysfunctional in various psychiatric disorders. Many studies have suggested so far that, in schizophrenia patients, GABAergic inhibition is selectively but consistently reduced in the prefrontal cortex (PFC).
This study used a computational model of the PFC to investigate the dynamics of the PFC circuit with and without chandelier cells and other GABAergic interneurons. The inhibition by GABAergic interneurons other than chandelier cells effectively regulated the PFC activity with rather low or modest levels of dopaminergic neurotransmission. This activity of the PFC is associated with normal cognitive functions and has an inverted-U shaped profile of dopaminergic modulation. In contrast, the chandelier cell-type inhibition affected only the PFC circuit dynamics in hyperdopaminergic conditions. Reduction of chandelier cell-type inhibition resulted in bistable dynamics of the PFC circuit, in which the upper stable state is associated with a hyperactive mode. When both types of inhibition were reduced, this hyperactive mode and the conventional inverted-U mode merged.
The results of our simulation suggest that, in schizophrenia, a reduction of GABAergic inhibition increases vulnerability to psychosis by (i) producing the hyperactive mode of the PFC with hyperdopaminergic neurotransmission by dysfunctional chandelier cells and (ii) increasing the probability of the transition to the hyperactive mode from the conventional inverted-U mode by dysfunctional GABAergic interneurons.
- Pyramidal Neuron
- GABAergic Interneuron
- Axonal Initial Segment
- GABAergic Inhibition
A number of studies have suggested alterations of the gamma-aminobutyric acid (GABA) system in the brains of patients with schizophrenia (for reviews: [1–5]). The alteration of GABAergic neurotransmission in the cortex seems to be selective for subpopulations of the interneurons [4–7]. Postmortem studies by Benes and colleagues reported decreased densities of interneurons in layer II of the prefrontal cortex (PFC) and layers II-IV of the cingulate cortex of patients with schizophrenia [8, 9]. Possibly owing to its compensation, GABAA receptors were observed to be upregulated in layers II, III, V and VI in the PFC and layers II and III in the cingulate cortex [10, 11]. Decreased densities of the interneurons in the PFC and the cingulate cortex might be restricted to the interneurons expressing calbindin; whether the densities of calretinin (CR)- or parvalbumin (PV)-interneurons are reduced or not is still uncertain [6, 12–14].
Analyses of postmortem brains of patients with schizophrenia have shown consistent reduction of reelin, PV, and GAD67, the 67-kilodalton isoform of glutamic acid decarboxylase [15–17]. Reelin is secreted preferentially by cortical GABAergic interneurons in layers I, II and IV and binds to integrin receptors on dendritic spines of pyramidal neurons or on GABAergic interneurons in layers III-V expressing the disabled-1 gene product (DAB1) [15, 18]. The expression of reelin mRNA was decreased in GABAergic interneurons in layers I, II and IV of schizophrenia patients . Because reelin plays a role in neuronal migration and synaptic plasticity in the cerebral cortex [18, 20, 21], the reduction of reelin in schizophrenia would indicate a neurodevelopmental abnormality that induces a GABAergic deficit in schizophrenia [1, 21]. Reduced levels of mRNA for GAD67 in the dorsolateral prefrontal cortex (DLPFC) of patients with schizophrenia suggest that GABA synthesis is reduced in schizophrenia [22–25]. The reduction was detected in about 25-30% of the GABAergic interneurons in the DLPFC [25, 26]. Among many subtypes of GABAergic interneurons in the cortex, the PV-interneurons contain basket cells and chandelier cells, which constitute 20-25% of GABAergic interneurons in the primate DLPFC . The GABAergic interneurons that show GAD67 mRNA reduction express PV , suggesting that the reduction is selective. Lewis and coworkers suggested that the density of the GABA membrane transporter (GAT1)-immunoreactive axon cartridges of chandelier cells was decreased by 40% in schizophrenic subjects compared to both normal controls and subjects with other psychotic disorders [29, 30]. They argued that the reduction was due to a decrease in the number of axon terminals rather than the number of chandelier cells [29, 30]. In contrast, the CR-positive GABAergic interneurons, which constitute about 50%, were unaffected .
The regulation of GABAergic neurotransmission is critical for proper information processing in the brain. For example, Goldman-Rakic and coworkers demonstrated that iontophoretic application of bicuculline methiodide, a competitive antagonist of GABAA receptors, into the DLPFC of monkeys performing an oculomotor delayed response task resulted in the destruction of spatial tuning of both pyramidal neurons and GABAergic interneurons . This has been reproduced in computational studies, which suggests that isodirectional intracortical inhibition contributes to the stability of the cortical circuit and cross-directional inhibition contributes to the spatial tuning or selectivity of working memory to represent [32–34]. Therefore, the alteration of GABAergic neurotransmission in the cortex would cause dysregulation of the circuit dynamics, resulting in the impairment of working memory and other cognitive functions.
A recent neurophysiological study of rats  suggests that chandelier cells, whose spontaneous activity is fairly low, are reserved to prevent excessive firing of neurons in the circuit. Chandelier cells are characterized by their synapses on the axonal initial segment of pyramidal neurons and the reduction of GABAergic neurotransmission in cortical circuits by this type of interneurons might lead to disinhibitory overactivation of the cortex, such as epileptic activity . Given that the density of the axon terminals of chandelier cells is reduced in schizophrenia, as suggested by postmortem studies [30, 37], one of the consequences of the circuit abnormality in schizophrenia would be hyperexcitability of the cortex.
Early functional imaging studies reported reduced responses of the DLPFC or hypofrontality in patients with schizophrenia [38–41]. Many recent studies suggest overactivation of the DLPFC during performing working memory tasks [42–45] or both greater and less activation of subareas in the DLPFC [46, 47]. The DLPFC would be basically hypodopaminergic, according to the dopamine (DA) hypothesis of schizophrenia . In this situation, the GABAergic inhibition in the DLPFC is not strong. Increasing the DA release in the DLPFC increases glutamatergic neurotransmission through N-methyl-D-aspartate (NMDA) receptors by D1 receptor stimulation. Then, the activity of the DLPFC increases with the DA release in the DLPFC. Under hyperdopaminergic conditions, the GABAergic inhibition becomes so strong that it highly suppresses noisy signal neurotransmission in the DLPFC circuit . The DLPFC activity thus shows an inverted-U shaped profile of the dopaminergic modulation [50, 51]. The profile would be sensitive to the strength of the GABAergic inhibition because the decreasing phase of the inverted-U shaped curve critically depends on the GABAergic inhibition in the DLPFC [49–51]. Therefore, if the GABAergic inhibition in the DLPFC is weakened, as has been observed in schizophrenia, the activity of the DLPFC would be significantly different. In this case, neurons in the DLPFC would exhibit hyperexcitation due to high NMDA currents under hyperdopaminergic conditions [49, 52].
Psychostimulants generally increase DA release from dopaminergic neurons . Psychotic states induced by psychostimulants are accompanied by the focal activation of the PFC, and the activity has a positive correlation with a psychotic symptom [54, 55]. Therefore, hyperdopaminergic neurotransmission and hyperactivity would characterize the PFC in acute psychotic states. The conventional inverted-U shape characteristic of dopaminergic modulation of the PFC activity , however, does not predict this. It rather predicts hypoactivity of the PFC with hyperdopaminergic neurotransmission. This unresolved issue would be an obstacle for advancing our understanding of the circuit mechanisms of schizophrenia. Recently, the circuit dynamics of the PFC under dopaminergic modulation has been studied using a computational model of the PFC circuit [34, 56–59]. This model predicts how the circuit dynamics of the PFC varies with D1 receptor activation. The stability of the PFC circuit varies with the D1 receptor activation when the operating point of the circuit moves along the inverted-U shaped curve. Using this model, Tanaka and coworkers extended the range of the D1 receptor activation to extremely high levels, and showed that hyperactivation of the PFC can occur under hyperdopaminergic conditions (they termed this the 'H mode') . Our study in this article uses essentially the same model and will explore the roles of GABAergic inhibition in the regulation of such dynamics of the PFC circuit. The result will show that 'chandelier cell-type inhibition' controls the H mode activity. GABAergic interneurons other than chandelier cells do not regulate this hyperactive mode effectively. Instead, these GABAergic interneurons regulate the conventional inverted-U shape mode of PFC activity. With these results, we will discuss the roles of GABAergic inhibition in the regulation and dysregulation of PFC circuit dynamics. The aim of this article is to investigate how the GABAergic abnormalities observed in the patients with schizophrenia alter the PFC circuit dynamics. Preliminary results have been published in an abstract form .
Mode diagram of the PFC
The above equation does not contain the term for the chandelier cells (or W cp = 0) because we first see the circuit dynamics of the PFC without chandelier cells. The relationship between x p and z in the above equation gives the mode diagram, which is identical to the curves for the equilibrium states in Figure 1. The equilibrium state has two typical modes of the PFC activity in the different range of D1 receptor activation, z. One is the inverted-U mode (1.0 <z < 4.3) and the other is the H mode (z > 6). There is a gap between these modes (4.3 <z < 6), in which the activity of the PFC is suppressed. Beyond z = 6, the PFC has two branches of activity. The upper branch is stable while the lower branch is unstable, as shown below, meaning that the dynamics of the PFC circuit is bistable. Therefore, once the PFC activity becomes higher than the unstable branch, the activity increases to reach the upper stable branch, whereas PFC activity that is lower than the unstable branch decreases to zero.
These are the equilibrium conditions for the two populations of neurons. The intersections of these nullclines indicate, therefore, the equilibrium states of the whole circuit or the fixed points. The figure shows three different conditions, mentioned above; i.e., the inverted-U mode (Figure 2A), the inactive state (Figure 2B), and the H mode (Figure 2C). The inverted-U mode has a single stable fixed point, indicated by a circle in Figures 2A and 2A1. The inactive state has no intersection between the two nullclines, so that only the state x p = x n = 0 is stable. In the H mode condition, there are two intersections of the nullclines or fixed points. Among these, the lower fixed point, indicated by a cross, is unstable, whereas the higher fixed point, indicated by a circle, is stable. This stable fixed point characterizes the H mode by hyperactivity of the PFC neurons.
Roles of GABAergic inhibition
A summary of the variations of the parameter values of the two different types of GABAergic inhibition used in the simulation.
Other GABA neurons
Chandelier cells vs other GABAergic interneurons
Our computational studies suggest that the dopaminergic modulation profile of PFC activity is complex rather than just an inverted U. A remarkable thing is the possibility of the existence of the H mode or hyperactive mode of the PFC with hyperdopaminergic neurotransmission. Both this mode and the conventional inverted-U mode activity of the PFC under the dopaminergic modulation would be regulated by GABAergic neurotransmission. However, the simulation in this article suggests that these modes have different sensitivities to different types of GABAergic inhibition. The H mode is sensitive to the GABAergic inhibition by chandelier cells, whereas the inverted-U mode is sensitive to the inhibition by GABAergic interneurons other than chandelier cells. The emergence of the H mode is, therefore, critically dependent on the strength of the chandelier cell-type inhibition. Stronger inhibition of this type puts the H mode away from the inverted-U mode. This means that, when the GABAergic inhibition by chandelier cells is reduced, as suggested in schizophrenia, the H mode is considered to be closer to the inverted-U mode than in healthy controls. On the other hand, the profile of the inverted-U mode is critically dependent on the inhibition by GABAergic interneurons other than chandelier cells. If this type of inhibition is stronger, the inverted-U mode easily disappears. With weaker inhibition of this type, in contrast, the profile of the inverted-U mode becomes larger. If both types of inhibition are reduced, therefore, the inverted-U mode and the H mode would merge into a single mode. As a result, the state of the PFC would be able to move to the H mode from the inverted-U mode.
Transition to the H mode
Functional magnetic resonance imaging (fMRI) studies of patients with schizophrenia using a verbal fluency task showed that increasing task demand produced greater activation of the PFC with higher error rates in psychotic states compared with remission . A recent fMRI study suggested an association between reality distortion and hyperactivity of the medial PFC of patients with schizophrenia or schizoaffective disorders . Besides these, 'it is postulated that before experiencing psychosis, patients [with schizophrenia] develop an exaggerated release of DA, independent of and out of synchrony with the context' . Downregulation of GABAergic neurotransmission in the PFC has consistently been associated with schizophrenia [1–5, 15]. These support our theory that psychotic states are induced by the transition to the H mode due to reduced GABAergic inhibition in the PFC with hyperdopaminergic neurotransmission.
Ketamine and amphetamines induced focal activation of the PFC in healthy subjects [54, 63, 64] and in patients with schizophrenia . In either schizophrenia or drug addiction, therefore, psychosis is associated with selective or focal activation of the cortex [54, 63–65]. NMDA antagonists, such as phencyclidine and ketamine, increase the extracellular DA concentration in the PFC [66–68]. It has been suggested that acute administration of psychostimulants, such as amphetamines and cocaine, increases the extracellular DA level significantly not only in the subcortical areas but in the PFC [69, 70]. A microdialysis study reported that intraperitoneal administration of 2 mg/kg of amphetamine to rats induced six-fold increase in the baseline DA concentration in the PFC , which could activate D1 receptors in the PFC. Recent studies reported that ketamine, an NMDA antagonist, decreased the expression of PV and GAD67 in mice [71, 72], suggesting reduced GABAergic inhibition in the PFC. Therefore, the underlying circuit mechanism of substance-induced psychosis might be the same with schizophrenic psychosis; that is, the transition to the H mode due to reduced GABAergic inhibition in the PFC with hyperdopaminergic neurotransmission.
Upregulation of D1 receptors
In contrast to acute administration, chronic administration of psychostimulants lowers the extracellular concentration of DA in the PFC [73, 74], which would induce sensitization of DA receptors. Similarly, the sensitization of DA receptors would be expected in patients with schizophrenia. A positron emission tomography (PET) study, using [11C]NNC 112 as a radiotracer, observed an increase in the binding potential of D1 receptors in the PFC of schizophrenia patients . This would reflect a chronically reduced extracellular DA concentration and an increase in the density of D1 receptors. Upregulation or sensitization of D1 receptors might be involved in schizophrenia. An increase in the DA releasability or the responsivity of dopaminergic neurons has also been suggested [76, 77]. These situations would increase the z value in the model, thereby increasing susceptibility to the H mode.
Acute stress increases DA turnover in the PFC, which leads to the impairment of cognitive functions [78, 79]. It seems that metabolic activity of dopaminergic neurons innervating the PFC is increased selectively in the PFC . The administration of the stressor FG 7142 also increases DA turnover in the PFC [81, 82]. Chronic stress induced hypodopaminergic states, and, again, impaired cognitive functions . In this case, Bmax or the density of D1 receptors in rat PFC was significantly increased (from 14.5 with 2.9 SD to 22.3 with 3.5 SD). Interestingly, either the hyperdopaminergic state or the hypodopaminergic state with D1 upregulation could lead to the H mode, according to the above arguments.
People with epilepsy are susceptible to schizophrenia-like psychosis [84–86]. The association between epilepsy and schizophrenia-like psychosis has long attracted much attention [87, 88], and would be interesting to know the commonalities between epilepsy and schizophrenia and the mechanisms underlying both diseases. Epilepsy is accompanied by excessive excitation of neuronal circuits in the brain [89, 90]. Many studies have suggested selective alterations in GABAA receptor subtypes in patients with epilepsy [91, 92]. DeFelipe proposed the hypothesis that the chandelier cell is a key component of cortical circuits in the establishment of epilepsy . Links to dopaminergic mechanisms have also been suggested [93, 94]. Using whole-cell recording and voltage-sensitive dye imaging techniques in the rat PFC, Bandyopadhyay et al.  demonstrated that bath application of SKF 81297, a selective D1 receptor agonist, enhanced spatiotemporal spread of activity in response to weak stimulation and previously subthreshold stimulation resulted in epileptiform activity that spread across the whole cortex. This result indicates that DA, via a D1 receptor-mediated mechanism, enhances spatiotemporal spread of neuronal activity and lowers the threshold for epileptiform activity in local circuits within the PFC. A rat study suggested that the supersensitivity of the DA systems, which was developed in the chronic phase of the kainate-induced temporal lobe epilepsy, was responsible for the genesis of epileptic psychosis . The H mode hypothesis is consistent with all of these results.
Enhanced cortical inputs
Because of the bistable nature of the H mode, the occurrence of the H mode critically depends on the strength of inputs. They are mediated by corticocortical or thalamocortical afferents to the PFC, and would be modulated by several ways, including dopaminergic modulation. It has also been suggested that DA has a sensorimotor gating function in PFC and subcortical circuits [96–99]. In fact, many studies have reported deficits in the sensorimotor gating function in patients with schizophrenia (for reviews: [98, 100, 101]) and, interestingly, also in amphetamine-sensitized animals . When a dysregulated or unfiltered input is given to the PFC, the PFC would respond to it with hyperactivity. Recent neurophysiological study in monkey reported an enhancement of the response-period activity of DLPFC neurons, but no effect on delay-period activity, by the stimulation of the D2 receptors in the DLPFC . This may suggest that D2 receptors are involved in gating afferent input to the DLPFC circuit for working memory and other cognitive functions. Moreover, if D2 receptors are supersensitive [104, 105], the H mode would more readily emerge because hyperactivation of D2 receptors could contribute to the enhancement of the input to the PFC.
We have investigated how GABAergic inhibition by chandelier cells and other GABAergic interneurons contribute to the regulation of neuronal activity in the PFC circuit. The results show that the roles of the two different types of GABAergic inhibition on PFC circuit dynamics are markedly different. The inhibition by GABAergic interneurons other than chandelier cells effectively regulates the PFC activity with rather low or modest levels of dopaminergic neurotransmission, which has an inverted-U shaped profile of dopaminergic modulation and is associated with normal cognitive functions. In contrast, the chandelier cell-type inhibition regulates the PFC activity with hyperdopaminergic neurotransmission. Therefore, dysfunction of chandelier cells in the PFC would produce the H mode, a "psychotic" hyperactive state with hyperdopaminergic neurotransmission. Reduction of the inhibition by other GABAergic interneurons would make the transition to the H mode more readily occur, thereby increasing vulnerability to psychosis.
Prefrontal Cortical Circuit Model
where fmax is the maximum firing rate. The activation function for the chandelier cell population will be given below. The simulation used the values of the parameters in the above equations as: fmax = 100 sp/s, τ p = 20.0, τ c (0) = τ n (0) = 5.0, W pp (0) = 0.00055, W pc (0) = W pn (0) = 0.00035, W cp = 0.0002, and W np = 0.0005.
Dopaminergic Modulation via D1 Receptors
where a, b and c are constants (a = 0.2, b = 0.4, c = 0.3).
This work was supported partly by the Sophia University Open Research Center grant. The author acknowledges the discussions with Hiroaki Ebi toward the construction of the computational model used in this study.
- Benes FM, Berretta S: GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology. 2001, 25: 1-27.PubMedGoogle Scholar
- Lewis DA, Gonzalez-Burgos G: Pathophysiologically based treatment interventions in schizophrenia. Nat Med. 2006, 12: 1016-1022.PubMedGoogle Scholar
- Lewis DA, Moghaddam B: Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol. 2006, 63: 1372-1376.PubMedGoogle Scholar
- Reynolds GP, Zhang ZJ, Beasley CL: Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity. Brain Res Bull. 2001, 55 (5): 579-584.PubMedGoogle Scholar
- Guidotti A, Auta J, Davis JM, Dong E, Grayson DR, Veldic M, Zhang X, Costa E: GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl). 2005, 180: 191-205.Google Scholar
- Beasley CL, Zhang ZJ, Patten I, Reynolds GP: Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry. 2002, 52 (7): 708-715.PubMedGoogle Scholar
- Reynolds GP, Beasley CL: GABAergic neuronal subtypes in the human frontal cortex – development and deficits in schizophrenia. J Chem Neuroanat. 2001, 22 (1–2): 95-100.PubMedGoogle Scholar
- Benes FM: Emerging principles of altered neural circuitry in schizophrenia. Brain Res Rev. 2000, 31: 251-269.PubMedGoogle Scholar
- Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL: Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 1991, 48 (11): 996-1001.PubMedGoogle Scholar
- Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP: Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci. 1992, 12 (3): 924-929.PubMedGoogle Scholar
- Benes FM, Vincent SL, Marie A, Khan Y: Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience. 1996, 75 (4): 1021-1031.PubMedGoogle Scholar
- Cotter D, Landau S, Beasley C, Stevenson R, Chana G, MacMillan L, Everall I: The density and spatial distribution of gabaergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biological Psychiatry. 2002, 51: 377-386.PubMedGoogle Scholar
- Reynolds GP, Beasley CL, Zhang ZJ: Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons. J Neural Transm. 2002, 109 (5-6): 881-889.PubMedGoogle Scholar
- Woo TU, Miller JL, Lewis DA: Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry. 1997, 154: 1013-1015.PubMedGoogle Scholar
- Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry. 2000, 57 (11): 1061-1069.PubMedGoogle Scholar
- Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E: A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA. 1998, 95 (26): 15718-15723.PubMed CentralPubMedGoogle Scholar
- Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB: Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry. 2005, 57 (3): 252-260.PubMedGoogle Scholar
- Pesold C, Impagnatiello F, Pisu MG, Uzunov DP, Costa E, Guidotti A, Caruncho HJ: Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc Natl Acad Sci USA. 1998, 95: 3221-3226.PubMed CentralPubMedGoogle Scholar
- Veldic M, Caruncho HJ, Liu WS, Davis J, Satta R, Grayson DR, Guidotti A, Costa E: DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc Natl Acad Sci USA. 2004, 101: 348-353.PubMed CentralPubMedGoogle Scholar
- Herz J, Chen Y: Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev Neurosci. 2006, 7 (11): 850-859.PubMedGoogle Scholar
- Tueting P, Doueiri MS, Guidotti A, Davis JM, Costa E: Reelin down-regulation in mice and psychosis endophenotypes. Neurosci Biobehav Rev. 2006, 30 (8): 1065-1077.PubMedGoogle Scholar
- Akbarian S, Huang HS: Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev. 2006, 52: 293-304.PubMedGoogle Scholar
- Lewis DA, Hashimoto T, Volk DW: Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 2005, 6 (4): 312-324.PubMedGoogle Scholar
- Volk DW, Lewis DA: Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav. 2002, 77 (4-5): 501-505.PubMedGoogle Scholar
- Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA: Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry. 2000, 57 (3): 237-245.PubMedGoogle Scholar
- Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE, Jones EG: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995, 52 (4): 258-266.PubMedGoogle Scholar
- Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 2003, 23 (15): 6315-6326.PubMedGoogle Scholar
- Zaitsev AV, Gonzalez-Burgos G, Povysheva NV, Kroner S, Lewis DA, Krimer LS: Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb Cortex. 2004, 15 (8): 1178-1186.PubMedGoogle Scholar
- Lewis DA: GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res Rev. 2000, 31 (2–3): 270-276.PubMedGoogle Scholar
- Woo T-U, Whitehead RE, Melchitzky DS, Lewis DA: A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA. 1998, 95: 5341-5346.PubMed CentralPubMedGoogle Scholar
- Rao SG, Williams GV, Goldman-Rakic PS: Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J Neurosci. 2000, 20: 485-494.PubMedGoogle Scholar
- Tanaka S: Architecture and dynamics of the primate prefrontal cortical circuit for spatial working memory. Neural Networks. 1999, 12: 1007-1020.PubMedGoogle Scholar
- Tanaka S: Roles of intracortical inhibition in the formation of spatially tuned delay-period activity of prefrontal neurons: computational study. Prog Neuro-Psychopharm & Biol Psychiat. 2000, 24: 483-504.Google Scholar
- Tanaka S: Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective. Neuroscience. 2006, 139: 153-171.PubMedGoogle Scholar
- Zhu Y, Stornetta RL, Zhu JJ: Chandelier cells control excessive cortical excitation: characteristics of whisker-evoked synaptic responses of layer 2/3 nonpyramidal and pyramidal neurons. J Neurosci. 2004, 24 (22): 5101-5108.PubMedGoogle Scholar
- DeFelipe J: Chandelier cells and epilepsy. Brain. 1999, 122 (Pt 10): 1807-1822.PubMedGoogle Scholar
- Pierri JN, Chaudry AS, Woo T-UW, Lewis DA: Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry. 1999, 156: 1709-1719.PubMedGoogle Scholar
- Andreasen NC, Rezai K, Alliger R, Swayze VW, Flaum M, Kirchner P, Cohen G, O'Leary DS: Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry. 1992, 49 (12): 943-958.PubMedGoogle Scholar
- Carter CS, Perlstein P, Ganguli R, Brar J, Mintun M, Cohen JD: Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry. 1998, 155: 1285-1287.PubMedGoogle Scholar
- Paulman RG, Devous MD, Gregory RR, Herman JH, Jennings L, Bonte FJ, Nasrallah HA, Raese JD: Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biol Psychiatry. 1990, 27 (4): 377-399.PubMedGoogle Scholar
- Weinberger DR, Berman KF: Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia. Schizophr Bull. 1988, 14 (2): 157-168.PubMedGoogle Scholar
- Manoach DS: Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophr Res. 2003, 60: 285-298.PubMedGoogle Scholar
- Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, Saper CB, Warach S: Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biological Psychiatry. 1999, 45: 1128-1137.PubMedGoogle Scholar
- Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, Saper CB, Rauch SL: Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry. 2000, 48 (2): 99-109.PubMedGoogle Scholar
- Thermenos HW, Goldstein JM, Buka SL, Poldrack RA, Koch JK, Tsuang MT, Seidman LJ: The effect of working memory performance on functional MRI in schizophrenia. Schizophr Res. 2005, 74 (2–3): 179-194.PubMedGoogle Scholar
- Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, Goldberg TE, Weinberger DR: Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex. 2000, 10 (11): 1078-1092.PubMedGoogle Scholar
- Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR: Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatry. 2003, 160: 2209-2215.PubMedGoogle Scholar
- Kahn RS, Davis KL: New developments in dopamine and schizophrenia. Psychopharmacology – The Fourth Generation of Progress. 2000, [http://www.acnp.org/G4/GN401000115/CH113.html]Google Scholar
- Williams GV, Castner SA: Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience. 2006, 139 (1): 263-276.PubMedGoogle Scholar
- Goldman-Rakic PS, Muly EC, Williams GV: D1 receptors in prefrontal cells and circuits. Brain Res Rev. 2000, 31 (2–3): 295-301.PubMedGoogle Scholar
- Muly EC, Szigeti K, Goldman-Rakic PS: D1 receptor in interneurons of macaque prefrontal cortex: distribution and subcellular localization. J Neurosci. 1998, 15: 10553-10565.Google Scholar
- Seamans JK, Durstewitz D, Christie B, Stevens CF, Sejnowski TJ: Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortical neurons. Proc Natl Acad Sci USA. 2001, 98: 301-306.PubMed CentralPubMedGoogle Scholar
- Feldman RS, Meyer JS, Quenzer LF: Principles of neuropsychopharmacology. 1997, Sunderland: SinauerGoogle Scholar
- Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D: Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry. 1997, 154 (6): 805-811.PubMedGoogle Scholar
- Vollenweider FX, Leenders KL, Scharfetter C, Antonini A, Maguire P, Missimer J, Angst J: Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol. 1997, 7 (1): 9-24.PubMedGoogle Scholar
- Tanaka S: Stable and unstable activation of the prefrontal cortex with dopaminergic modulation. Monoaminergic Modulation of Cortical Excitability. Edited by: Kuei-Yuan Tseng, Marco Atzori. 2007, New York: Springer, 235-246.Google Scholar
- Tanaka S: A circuit dynamics theory of complex dopaminergic modulation of prefrontal cortical activity and its relevance to schizophrenia. Dopamine Research Advances. Edited by: Akiyama Watanabe. 2007, New York: Nova Science Pub, 17-50.Google Scholar
- Tanaka S, Ebi H, Yamashita K: A new mode beyond the inverted-U region of the dopaminergic modulation of the prefrontal cortex. Neurocomputing. 2006, 69 (10–12): 1146-1149.Google Scholar
- Tanaka S, Sakata K, Horiguchi R, Ebi H: A specific role of chandelier cell-type inhibition in prefrontal cortical circuit dynamics: implications for schizophrenia. Soc Neurosci Abstr. 2007, 806: 14.Google Scholar
- Fu CH, Suckling J, Williams SC, Andrew CM, Vythelingum GN, McGuire PK: Effects of psychotic state and task demand on prefrontal function in schizophrenia: an fMRI study of overt verbal fluency. Am J Psychiatry. 2005, 162 (3): 485-494.PubMedGoogle Scholar
- Taylor SF, Welsh RC, Chen AC, Velander AJ, Liberzon I: Medial frontal hyperactivity in reality distortion. Biol Psychiatry. 2007, 61 (10): 1171-1178.PubMedGoogle Scholar
- Kapur S: Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003, 160: 13-23.PubMedGoogle Scholar
- Mattay VS, Berman KF, Ostrem JL, Esposito G, Van Horn JD, Bigelow LB, Weinberger DR: Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study. J Neurosci. 1996, 16: 4816-4822.PubMedGoogle Scholar
- Uftring SJ, Wachtel SR, Chu D, McCandless C, Levin DN, Wit Hd: An fMRI study of the effect of amphetamine on brain activity. Neuropsychopharmacology (Nature). 2001, 25: 925-935.Google Scholar
- Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S, Bigelow LB, Goldberg TE, Berman KF, Kleinman JE: The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci. 1991, 11: 1907-1917.PubMedGoogle Scholar
- Adams B, Moghaddam B: Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci. 1998, 18: 5545-5554.PubMedGoogle Scholar
- Hondo H, Yonezawa Y, Nakahara T, Nakamura K, Hirano M, Uchimura H, Tashiro N: Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study. Brain Res. 1994, 633 (1–2): 337-342.PubMedGoogle Scholar
- Verma A, Moghaddam B: NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci. 1996, 16 (1): 373-379.PubMedGoogle Scholar
- Shoblock JR, Maisonneuve IM, Glick SD: Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex. Neurochem Res. 2004, 29 (7): 1437-1442.PubMedGoogle Scholar
- Stephans SE, Yamamoto BY: Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res. 1995, 700 (1–2): 99-106.PubMedGoogle Scholar
- Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, Dugan LL: Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science. 2007, 318: 1645-1647.PubMedGoogle Scholar
- Kinney JW, Davis CN, Tabarean I, Conti B, Bartfai T, Behrens MM: A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci. 2006, 26: 1604-1615.PubMedGoogle Scholar
- Castner SA, Vosler PS, Goldman-Rakic PS: Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex. Biol Psychiatry. 2005, 57 (7): 743-751.PubMedGoogle Scholar
- Pierce RC, Kalivas PW: A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev. 1997, 25 (2): 192-216.PubMedGoogle Scholar
- Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang D-R, Keilp J, Kochan L, Heertum RV, Gorman JM, Laruelle M: Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci. 2002, 22: 3708-3719.PubMedGoogle Scholar
- Laruelle M: The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies. Brain Res Rev. 2000, 31: 371-384.PubMedGoogle Scholar
- Lieberman JA, Sheitman BB, Kinon BJ: Neurochemical Sensitization in the Pathophysiology of Schizophrenia: Deficits and Dysfunction in Neuronal Regulation and Plasticity. Neuropsychopharmacology. 1997, 17: 205-229.PubMedGoogle Scholar
- Arnsten AFT, Goldman-Rakic PS: Noise stress impairs prefrontal cortical cognitive function in monkeys. Arch Gen Psychiatry. 1998, 55: 362-368.PubMedGoogle Scholar
- Hutson PH, Patel S, Jay MT, Barton CL: Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist. Eur J Pharmacol. 2004, 484 (1): 57-64.PubMedGoogle Scholar
- Deutch AY, Lee MC, Gillham MH, Cameron DA, Goldstein M, Iadarola MJ: Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. Cereb Cortex. 1991, 1 (4): 273-292.PubMedGoogle Scholar
- Murphy BL, Arnsten AFT, Goldman-Rakic PS, Roth RH: Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci USA. 1996, 93: 1325-1329.PubMed CentralPubMedGoogle Scholar
- Murphy BL, Arnsten AFT, Jentsch JD, Roth RH: Dopamine and spatial working memory in rats and monkeys: pharmocaological reversal of stress-induced impairment. J Neurosci. 1996, 16: 7768-7776.PubMedGoogle Scholar
- Mizoguchi K, Yuzurihara M, Ishige A, Sasaki H, Chui DH, Tabira T: Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction. J Neurosci. 2000, 20 (4): 1568-1574.PubMedGoogle Scholar
- Qin P, Xu H, Laursen TM, Vestergaard M, Mortensen PB: Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study. BMJ. 2005, 331 (7507): 23.PubMed CentralPubMedGoogle Scholar
- Sachdev P: Schizophrenia-like psychosis and epilepsy: the status of the association. Am J Psychiatry. 1998, 155 (3): 325-336.PubMedGoogle Scholar
- Toone BK: The psychoses of epilepsy. J Neurol Neurosurg Psychiatry. 2000, 69 (1): 1-3.PubMed CentralPubMedGoogle Scholar
- Adachi N, Matsuura M, Hara T, Oana Y, Okubo Y, Kato M, Onuma T: Psychoses and epilepsy: are interictal and postictal psychoses distinct clinical entities?. Epilepsia. 2002, 43 (12): 1574-1582.PubMedGoogle Scholar
- Kanemoto K, Tsuji T, Kawasaki J: Reexamination of interictal psychoses based on DSM IV psychosis classification and international epilepsy classification. Epilepsia. 2001, 42 (1): 98-103.PubMedGoogle Scholar
- Avoli M, Louvel J, Pumain R, Kohling R: Cellular and molecular mechanisms of epilepsy in the human brain. Prog Neurobiol. 2005, 77 (3): 166-200.PubMedGoogle Scholar
- Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J: Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005, 46 (4): 470-472.PubMedGoogle Scholar
- Bowser DN, Wagner DA, Czajkowski C, Cromer BA, Parker MW, Wallace RH, Harkin LA, Mulley JC, Marini C, Berkovic SF, Williams DA, Jones MV, Petrou S: Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)] found in human epilepsy. Proc Natl Acad Sci USA. 2002, 99 (23): 15170-15175.PubMed CentralPubMedGoogle Scholar
- Loup F, Wieser HG, Yonekawa Y, Aguzzi A, Fritschy JM: Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci. 2000, 20 (14): 5401-5419.PubMedGoogle Scholar
- Ando N, Morimoto K, Watanabe T, Ninomiya T, Suwaki H: Enhancement of central dopaminergic activity in the kainate model of temporal lobe epilepsy: implication for the mechanism of epileptic psychosis. Neuropsychopharmacology. 2004, 29 (7): 1251-1258.PubMedGoogle Scholar
- Starr MS: The role of dopamine in epilepsy. Synapse. 1996, 22 (2): 159-194.PubMedGoogle Scholar
- Bandyopadhyay S, Gonzalez-Islas C, Hablitz JJ: Dopamine enhances spatiotemporal spread of activity in rat prefrontal cortex. J Neurophysiol. 2005, 93 (2): 864-872.PubMedGoogle Scholar
- Braff DL, Geyer MA, Swerdlow NR: Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001, 156 (2–3): 234-258.Google Scholar
- Braver TS, Barch DM, Cohen JD: Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol Psychiatry. 1999, 46 (3): 312-328.PubMedGoogle Scholar
- Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR: Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl). 2001, 156 (2–3): 117-254.Google Scholar
- Swerdlow NR, Shoemaker JM, Kuczenski R, Bongiovanni MJ, Neary AC, Tochen LS, Saint Marie RL: Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation. Neurosci Lett. 2006, 402 (1–2): 40-45.PubMedGoogle Scholar
- Braff DL, Freedman R: Endophenotypes in studies of the genetics of schizophrenia. Neuropsychopharmacology: The Fifth Generation of Progress. Edited by: Kenneth L Davis, Dennis Charney, Joseph T Coyle, Charles Nemeroff. 2002, Lippincott Williams & Wilkins, 703-816.Google Scholar
- Swerdlow NR, Geyer MA, Braff DL: Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl). 2001, 156: 194-215.Google Scholar
- Tenn CC, Fletcher PJ, Kapur S: Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr Res. 2003, 64 (2–3): 103-114.PubMedGoogle Scholar
- Wang M, Vijayraghavan S, Goldman-Rakic PS: Selective D2 receptor actions on the functional circuitry of working memory. Science. 2004, 303 (5659): 853-856.PubMedGoogle Scholar
- Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, Grandy DK, Premont RT, Sotnikova TD, Boksa P, El-Ghundi M, O'dowd BF, George SR, Perreault ML, Mannisto PT, Robinson S, Palmiter RD, Tallerico T: Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci USA. 2005, 102: 3513-3518.PubMed CentralPubMedGoogle Scholar
- Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T: Psychosis pathways converge via D2High dopamine receptors. Synapse. 2006, 60 (4): 319-346.PubMedGoogle Scholar
- Yamashita K, Tanaka S: Parametric study of dopaminergic neuromodulatory effects in a reduced model of the prefrontal cortex. Neurocomputing. 2005, 65–66: 579-586.Google Scholar
- Durstewitz D, Seamans JK, Sejnowski TJ: Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. J Neurophysiol. 2000, 83: 1733-1750.PubMedGoogle Scholar
- Howard A, Tamas G, Soltesz I: Lighting the chandelier: new vistas for axo-axonic cells. Trends Neurosci. 2005, 28 (6): 310-316.PubMedGoogle Scholar
- Wang XJ, Tegner J, Constantinidis C, Goldman-Rakic PS: Division of labor among distinct subtypes of inhibitory neurons in a cortical microcircuit of working memory. Proc Natl Acad Sci USA. 2004, 101 (5): 1368-1373.PubMed CentralPubMedGoogle Scholar
- Seamans JK, Yang CR: The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol. 2004, 74: 1-57.PubMedGoogle Scholar
- Yang CR, Seamans JK, Gorelova N: Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex. Neuropsychopharmacology. 1999, 21: 161-194.PubMedGoogle Scholar
- Gorelova N, Seamans JK, Yang CR: Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J Neurophysiol. 2002, 88 (6): 3150-3166.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.